Xenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that the company will present at the 2024 Bloom Burton & Co. Healthcare Investor Conference taking place April 16-17, 2024.

Company Presentation Details:

Date:
  Tuesday, April 16, 2024

Time:
  9:30 AM Eastern Time

Webcast:
  Register here

Presenters:
  Ian Mortimer, President and Chief Executive Officer
 

A live webcast of the company presentation will be available on the “Investors” section of Xenon’s website and posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Contacts:
For Investors:
Chad Fugere
Vice President, Investor Relations
(857) 675-7275
investors@xenon-pharma.com

For Media:
Jodi Regts
Xenon Corporate Affairs
(604) 484-3353
media@xenon-pharma.com

Staff

Recent Posts

Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network

PARIS and CHICAGO and NASHVILLE, Tenn., April 3, 2025 /PRNewswire/ -- Therapixel, creators of MammoScreen®, a…

4 hours ago

Dräger announces US availability of next- generation Polaris® OR lights

TELFORD, Pa., April 3, 2025 /PRNewswire/ -- Innovations in surgical light technology can help ORs…

4 hours ago

Services PMI® at 50.8%; March 2025 Services ISM® Report On Business®

Business Activity Index at 55.9%; New Orders Index at 50.4%; Employment Index at 46.2%; Supplier…

4 hours ago

GAIA Study Reveals Groundbreaking Links Between Nutrition, Mental Resilience, and Infectious Disease Recovery

New Research Highlights the Power of Whole Foods Plant-Based Diets in Burnout Reduction and COVID-19…

4 hours ago

ApolloMD Unveils Agentic AI Vision in Partnership with Adonis

Leading clinical outsourcing services organization expands partnership with AI orchestration platform to bring agentic AI…

4 hours ago

Sohar Health and Talkiatry Expand Access to Mental Health Care by Automating Insurance Eligibility Process

Behavioral health providers that streamline the insurance verification process improve the patient experience and increase…

4 hours ago